Opposing effects by glucocorticoid and bone morphogenetic protein-2 in fetal rat bone cell cultures

Journal of Cellular Biochemistry

Volumn 67, Issue 4, 1997, Pages 528-540

  Centrella, Michael ^a   Rosen, Vicki ^b   Wozney, John M ^b   Casinghino, Sandra R ^a   McCarthy, Thomas L ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b PFIZER INC   (United States)

Author keywords

Collagen; Gene promoters; Metabolic bone diseases; Osteogenesis; Receptors; Transforming growth factor (TGF 13)

Indexed keywords

ALKALINE PHOSPHATASE; BONE MORPHOGENETIC PROTEIN; COLLAGEN; DNA; GLUCOCORTICOID; HYDROCORTISONE; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR;

ANIMAL CELL; ARTICLE; CELL CULTURE; CELL DIFFERENTIATION; COLLAGEN SYNTHESIS; CONTROLLED STUDY; FETUS; NONHUMAN; OSTEOBLAST; PRIORITY JOURNAL; PROMOTER REGION; RAT;

NON-PROGRAMMATIC;

ACTIVIN RECEPTORS, TYPE I; ALKALINE PHOSPHATASE; ANIMALS; BONE MORPHOGENETIC PROTEINS; CELLS, CULTURED; COLLAGEN; DNA; FETUS; GLUCOCORTICOIDS; HUMANS; HYDROCORTISONE; KINETICS; OSTEOBLASTS; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROMOTER REGIONS (GENETICS); PROTEIN-SERINE-THREONINE KINASES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; RECOMBINANT PROTEINS; TRANSFECTION; TRANSFORMING GROWTH FACTOR BETA;

ANIMALIA;

EID: 0030682177     PISSN: 07302312     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4644(19971215)67:4<528::AID-JCB10>3.0.CO;2-5     Document Type: Article

References (59)

1. Adler RA, Rosen CJ (1994): Glucocorticoids and osteoporosis. Endocrinol Metab Clin North Am 23:641-654.
2. Baron R (1996): Anatomy and ultrastructure of bone. In MJ Favus (ed): "Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism," 3rd ed. New York: Raven Press, pp 3-10.
3. Beck LS, Ammann AJ, Aufdemorte TB, Deguzman L, Xu Y, Lee YP, McFatridge LA, Chen TL (1991): In vivo induction of bone by recombinant human transforming growth factor β1. J Bone Miner Res 6:961-968.
4. Bellows CG, Aubin JE, Heersche JNM (1987): Physiological concentrations of glucocorticoids stimulate formation of bone nodules from isolated rat calvarial cells in vitro. Endocrinology 121:1985-1992.
5. Bockman RS, Weinerman SA(1990): Steroid-induced osteoporosis. Orthop Clin North Am 21:97-107.
6. Bradford MM (1976): A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254.
7. Briner VA, Thiel G, Monier-Faugere MC, Bognar B, Landmann J, Kamber V, Malluche HH (1995): Prevention of cancellous bone loss but persistent renal bone disease despite normal 1,25 vitamin D levels two years after kidney transplantation. Transplantation 59:1393-1400.
8. Canalis E (1995): Growth hormone, skeletal growth factors and osteoporosis. Endocr Pract 1:39-43.
9. Carcamo J, Zentella A, Massague J (1995): Disruption of transforming growth factor β signaling by a mutation that prevents transphosphorylation within the receptor complex. Mol Cell Biol 15:1573-1581.
10. Celeste AJ, Ianazzi JA, Taylor RC, Hewick RM, Rosen V, Wang EA, Wozney JM (1990): Identification of transforming growth factor β family members present in bone-inductive protein purified from bovine bone. Proc Natl Acad Sci USA 87:9843-9847.
11. Centrella M (1993): Growth factor receptors and responses: Comparison between normal and osteosarcoma-derived cell cultures. In: "Frontiers in Osteosarcoma Research." Toronto: Hogrefe and Huber Inc., pp 469-481.
12. Centrella M, McCarthy TL, Canalis E (1987): Transforming growth factor β is a bifunctional regulator of replication and collagen synthesis in osteoblast-enriched cell cultures from fetal rat calvariae. J Biol Chem 262:2869-2874.
13. Centrella M, McCarthy TL, Canalis E (1988): Parathyroid hormone modulates transforming growth factor β activity and binding in osteoblastic cells. Proc Natl Acad Sci USA 85:5889-5893.
14. Centrella M, McCarthy TL, Canalis E (1989): β2-Microglobulin (β2m) enhances insulin-like growth factor I binding and synthesis in bone cell cultures. J Biol Chem 264:18268-18271.
15. Centrella M, McCarthy TL, Canalis E (1991): Glucocorticoid regulation of transforming growth factor β1 (TGF-β1) activity and binding in osteoblast-enriched cultures from fetal rat bone. Mol Cell Biol 11:4490-4496.
16. Centrella M, Casinghino S, McCarthy TL (1994): Differential actions of prostaglandins in separate cell populations from fetal rat bone. Endocrinology 135:1611-1620.
17. Centrella M, Rosen V, Horowitz MC, Wozney JM, McCarthy TL (1995a): Transforming growth factor-β gene family members, their receptors, and bone cell function. In DD Bikle, A Negro-Vilar (eds): "Hormonal Regulation of Bone Mineral Metabolism." Bethesda MD: Endocrine Society Press, pp 211-226.
18. Centrella M, Casinghino S, Kim J, Pham T, Rosen V, Wozney J, McCarthy TL (1995b): Independent changes in type I and type II receptors for transforming growth factor β induced by bone morphogenetic protein-2 parallel expression of the osteoblast phenotype. Mol Cell Biol 15:3273-3281.
19. Centrella M, Casinghino S, Gundberg C, McCarthy TL, Wozney J, Rosen V (1996a): Changes in bone morphogenetic protein (BMP) sensitivity relative to differentiation in fetal rat bone cell cultures. Ann NY Acad Sci 785:224-226.
20. Centrella M, Ji C, Casinghino S, McCarthy TL (1996b): Rapid flux in transforming growth factor β receptors on bone cells. J Biol Chem 271:18616-18622.
21. Chen RH, Miettinen PJ, Maruoka EM, Choy L, Derynck R (1995): A WD-domain protein that is associated with and phosphorylated by the type II TGF-β receptor. Nature 377:548-552.
22. Chen TL, Chang LY, Bates RL, Perlman AJ (1991): Dexamethasone and 1,25-dihydroxyvitamin D3 modulation of insulin-like growth factor binding proteins in rat osteoblast-like cell cultures. Endocrinology 128:73-80.
23. Derynck R, Zhang Y (1996): Intracellular signaling: The Mad way to do it. Curr Biol 6:1226-1229.
24. Dietrich JW, Canalis EM, Maina DM, Raisz LG (1978): Effects of glucocorticoids on fetal rat bone collagen synthesis in vitro. Endocrinology 104:715-721.
25. Goans RE, Weiss GH, Abrams SA, Perez MD, Yergey AL (1995): Calcium tracer kinetics show decreased irreversible flow to bone in glucocorticoid treated patients. Calcif Tissue Int 56:533-535.
26. Hughes FJ, Collyer J, Stanfield M, Goodman SA (1995): The effects of bone morphogenetic protein-2, -4, and -6 on differentiation of rat osteoblast cells in vitro. Endocrinology 136:2671-2677.
27. Ishidou Y, Kitajima I, Obama H, Maruyama I, Murata F, Imamura T, Yamada N, ten Dijke P, Miyazono K, Sakou T (1995): Enhanced expression of type I receptors for bone morphogenetic proteins during bone formation. J Bone Miner Res 10:1651-1659.
28. Ji C, Casinghino S, McCarthy TL, Centrella M (1996): Cloning, characterization and expression of a rat transforming growth factor-β type I receptor promoter. J Cell Biochem 63:478-490.
29. Kerstjens HA, Postmas DS, vanDormaal JJ, vanZanten AK, Brand PL, Dekhuijzen PN, Koeter GH (1994): Effects of short-term and long-term treatment with inhaled corticosteroids on bone metabolism in patients with airways obstruction. Thorax 49:652-656.
30. Kingsley DM (1994): The TGF-β superfamily: New members, new receptors, and new genetic tests of function in different organisms. Genes Dev 8:133-146.
31. Komm BS, Terpening CM, Benz DJ, Graeme KA, Gallegos A, Korc M, Greene GL, O'Malley BW, Haussler MR (1988): Estrogen binding receptor mRNA and biologic response in osteoblast-like osteosarcoma cells. Science 241:81-84.
32. Kream BE, Tetradis S, LaFrancis D, Fall PM, Feyen JHM, Raisz LG (1997): Modulation of the effects of glucocorticoids on collagen synthesis in fetal rat calvariae by insulin-like growth factor binding protein-2. J Bone Miner Res 12:889-895.
33. Lian JB, Stein GS (1993): The developmental stages of osteoblast growth and differentiation exhibit selective responses of genes to growth factors (TGF-β1) and hormones (vitamin D and glucocorticoids). J Oral Implantol 19:95-105.
34. Lowry OH (1957): Micromethods for the assay of enzymes. Methods Enzymol 4:366-381.
35. Lukert BP (1996): Glucocorticoid and drug-induced osteoporosis. In MJ Favus (ed): "Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism," 3rd ed. New York: Raven Press pp 278-282.
36. Lukert BP, Raisz LG (1990): Glucocorticoid-induced osteoporosis: pathogenesis and management. Ann Intern Med 112:352-364.
37. Marcelli C, Yates AJ, Mundy GR (1990): In vivo effects of human recombinant transforming growth factor β on bone turnover in normal mice. J Bone Miner Res 5:1087-1096.
38. Martin TJ, Ng KW, Suda T (1989): Bone cell physiology. Endocrinol Metab Clin North Am 18:833-858.
39. Marusic A, Kalinowski JF, Harrison JR, Centrella M, Raisz LG, Lorenzo JA (1991): Effects of transforming growth factor β and interleukin 1α on prostaglandin synthesis in serum-deprived osteoblastic cells. J Immunol 146:2633-2638.
40. Massague J, Attisano L, Wrana JL (1994): The TGF-β family and its composite receptors. Trends Cell Biol 4:172-178.
41. Mayer H, Scutt AM, Ankenbauer T (1996): Subtle differences in the mitogenic effects of recombinant human bone morphogenetic proteins -2 to -7 on DNA synthesis on primary bone forming cells and identification of BMP-2/4 receptor. Calc Tissue Int 58:249-255.
42. McCarthy TL, Centrella M, Canalis E (1988): Further biochemical and molecular characterization of primary rat parietal bone cell cultures. J Bone Miner Res 3:401-408.
43. McCarthy TL, Centrella M, Canalis E (1989): Parathyroid hormone enhances the transcript and polypeptide levels of insulin-like growth factor I in osteoblast-enriched cultures from fetal rat bone. Endocrinology 124:1247-1253.
44. McCarthy TL, Centrella M, Canalis E (1990): Cortisol inhibits the synthesis of insulin-like growth factor I in bone cell cultures. Endocrinology 126:1569-1575.
45. 2 in primary rat osteoblasts. J Biol Chem 271:6666-6671.
46. Miyazono K, ten Dijke P, Ichijo H, Heldin C-H (1994): Receptors for transforming growth factor-β. Adv Immunol 55:181-220.
47. Noda M, Camilliere JJ (1989): In vivo stimulation of bone formation by transforming growth factor-β. Endocrinology 124:2291-2294.
48. Peterkofsky B, Diegelmann R (1971): Use of a mixture of proteinase free collagenases for the specific assay of radioactive collagen in the presence of other proteins. Biochemistry 10:988-993.
49. Petkovich PM, Wrana JL, Grigoriadis AE, Heersche JNM, Sodek J (1987): 1,25 dihydroxyvitamin D3 increases epidermal growth factor receptors and transforming growth factor β-like activity in a bone-derived cell line. J Biol Chem 262:13424-13428.
50. Pfeilschifter J, Mundy GR (1987): Modulation of type β transforming growth factor activity in bone cultures by osteotropic hormones. Proc Natl Acad Sci USA 84:2024-2028.
51. Rosen V, Thies RS (1992): The BMP proteins in bone formation and repair. Trends Genet 8:97-102.
52. Rosen V, Nove J, Song JJ, Thies RS, Cox K, Wozney JM (1994): Responsiveness of clonal limb bud cell lines to bone morphogenetic protein 2 reveals a sequential relationship between cartilage and bone cell phenotypes. J Bone Miner Res 9:1759-1768.
53. Sumner DR, Turner TM, Purchio AF, Gombotz WR, Urban RM, Galante JO (1995): Enhancement of bone ingrowth by transforming growth factor-beta. J Bone Joint Surg 77:1135-1147.
54. Thies RS, Bauduy M, Ashton BA, Kurtzberg L, Wozney JM, Rosen V (1992): Recombinant human bone morphogenetic protein-2 induces osteoblastic differentiation in W-20-17 stromal cells. Endocrinology 130:1318-1324.
55. Truss M, Beato M (1993): Steroid hormone receptors: interaction with deoxyribonucleic acid and transcription factors. Endocrinol Rev 14:459-479.
56. Wieser R, Wrana JL, Massague J (1995): GS domain mutations that constitutively activate TGF-βR-I, the downstream signaling component in the TGF-β receptor complex. EMBO J 14:2199-2208.
57. Yamaguchi K, Shirakabe K, Shibuya H, Irie K, Oishi I, Ueno N, Taniguchi T, Nishida E, Matsumoto K (1995): Identification of a member of the MAPKKK family as a potential mediator of TGF-β signal transduction. Science 270:2009-2011.
58. Yen PM, Liu Y, Palvimo JJ, Trifiro M, Whang J, Pinsky L, Janne OA, Chin WW (1997): Mol Endocrinol 11:162-171.
59. Zou H, Niswander L (1996): Requirement for BMP signaling in interdigital apoptosis and scale formation. Science 272:738-741.